Pharmacoeconomic analysis of denosumab in patients with breast cancer and bone metastases

Pharmacoeconomic analysis of denosumab in patients with breast cancer and bone metastases

Skeletal-related events - a significant medical and economic problem for women with metastases during the treatment of breast cancer. Clinico-economic evaluation was performed to compare the use of denosumab and zoledronic acid in this category of patients. The recommended pharmacoeconomic methods s...

Full description

Bibliographic Details
Main Authors:	A. S. Kolbin, A. A. Kurylev, M. A. Proskurin, Yu. E. Balykina
Format:	Article
Language:	Russian
Published:	Izdatelstvo OKI 2018-05-01
Series:	Качественная клиническая практика
Subjects:	костные осложнения фармакоэкономика прямые затраты косвенные затраты деносумаб pharmacoeconomic analysis of denosumab in patients with breast cancer and bone metastases
Online Access:	https://www.clinvest.ru/jour/article/view/4

Similar Items

Клинико-экономический анализ профилактики послеоперационных венозных тромбоэмболических осложнений
Published: (2018-06-01)

Исследование медико-социальных проблем эпилепсии в России
Published: (2018-06-01)

ANALYSIS OF COST STRUCTURE FOR PHARMACOTHERAPY OF PATIENTS WITH STABLE ANGINA (THE CASE OF CARDIOLOGY DEPARTMENT OF TVER REGIONAL CLINICAL HOSPITAL)
by: M. A. Demidova, et al.
Published: (2015-12-01)

Клинико-экономическая оценка эффективности лечения больных с эпилепсией
Published: (2018-06-01)

Мультифакторный клиникоэкономический анализ эффективности применения современных атипичных антипсихотиков у больных с шизофренией
Published: (2018-06-01)

Interpretation of the pharmacoeconomical analysis in the context of rational choice of medicines
by: E E Loskutova, et al.
Published: (2013-12-01)

Клинико-экономическая оценка антибактериальной терапии интраабдоминальных инфекций
Published: (2018-06-01)

Pharmacoeconomic analysis of the use of botulinum toxin in the treatment of poststroke spasticity
by: A. S. Kolbin, et al.
Published: (2018-05-01)

Pharmacoeconomic analysis of Flemoclav Solutab® use in adult patients with acute sinusitis in routine outpatient clinical practice in Russia
by: A. S. Kolbin, et al.
Published: (2018-05-01)

Применение анализа «затраты-эффективность» для выбора препаратов из группы аналогов
Published: (2018-06-01)

Клинико-фармакологическая экспертиза лефлуномида при ревматоидном артрите
Published: (2018-06-01)

Клинико-экономический анализ Тимоглобулина для профилактики и лечения острой реакции отторжения трансплантата при пересадке почки
Published: (2018-06-01)

Pharmacoeconomic analysis of the use of ibrutinib in therapy of the first line of a chronic lymphocytic leukaemia for patients with 17p deletion
by: A. S. Kolbin, et al.
Published: (2018-05-01)

Клинико-экономическая оценка доцетаксела тригидратат (Таксотер) при адъювантной и химиотерапии первой линии рака молочной железы
Published: (2018-07-01)

Фармакоэкономический анализ эффективности применения актовегина, кавинтона и трентала у больных с дисциркуляторными энцефалопатиями
Published: (2018-06-01)

Фармакоэкономические аспекты применения статинов при краткосрочной гиполипидемической терапии
Published: (2018-06-01)

Management of bone metastases in refractory prostate cancer – role of denosumab
by: Paller CJ, et al.
Published: (2012-09-01)

Клинико-экономический анализ целесообразности внедрения стандартов лечения гипертонических кризов на догоспитальном этапе
Published: (2018-06-01)

Клинико-экономическое обоснование применение вильпрафена в лечении урогенитального хламидиоза
Published: (2018-06-01)

Клинико-экономический анализ оригинальной и генерической форм клопидогрела при ишемической болезни сердца после эндоваскулярных вмешательств
Published: (2018-06-01)

Оксалиплатин в химиотерапии рака толстой кишки: клиникоэкономический анализ
Published: (2018-06-01)

Treatment of medullary thyroid cancer with bone metastases with denosumab: A review and case illustration
by: Leslie S. Eldeiry, et al.
Published: (2020-09-01)

Pharmacoeconomic effectiveness of lenvatinib in patients with differentiated radioiodine-resistant thyroid cancer
by: S. K. Zyryanov, et al.
Published: (2018-05-01)

Pharmacoeconomical aspects of the treatment of arterial hypertension in patients with type II diabetes mellitus in outpatient department
by: J Sh Gushina, et al.
Published: (2009-03-01)

Pharmacoeconomics of chronic kidney disease
by: R. I. Yagudina, et al.
Published: (2018-02-01)

Четыре стратегии лечения анемий у онкологических больных в России
Published: (2018-06-01)

Фармакоэкономический анализ комбинированных ингаляционных средств для лечения бронхиальной астмы
Published: (2018-06-01)

Pharmacoeconomic analysis of vemurafenib and dabrafenib use in patients with inoperable or metastatic melanoma with BRAF V600 mutation
by: A. S. Kolbin, et al.
Published: (2018-05-01)

Direct taxes harmonization process in the EU: main results and trends
by: Y S Ranchinskaya
Published: (2012-03-01)

Pharmacoeconomic analysis of ranibizumab and aflibercept for treatment of diabetic macular edema
by: A. E. Cheberda, et al.
Published: (2018-05-01)

Pharmacoeconomics as an instrument of clinical pharmacology for optimization of pharmacotherapy (review)
by: O. V. Reshet'ko, et al.
Published: (2018-02-01)

Effectiveness of Bone Metastases Treatment by Sm-153 Oxabifore in Combination with Monoclonal Antibody Denosumab (Xgeva): First Experience
by: Nigora Rasulova, et al.
Published: (2013-01-01)

An update of pharmacoeconomic analysis of trastuzumab emtanzine in patients with HER2+ breast cancer and central nervous system metastases
by: A. S. Kolbin, et al.
Published: (2019-04-01)

Economic efficiency in health system and methods of its increase
by: E I Arkhipova, et al.
Published: (2009-12-01)

Клинико-экономическое сравнение инсулина гларгин и инсулина премикс аспарт при сахарном диабете типа 2
Published: (2018-07-01)

Фармакоэпидемиология острого коронарного синдрома. Отечественный анализ реальной практики назначений
Published: (2018-06-01)

Gosudarstvennyy registr bol'nykh sakharnym diabetom - osnovnaya informatsionnnaya sistema dlya rascheta ekonomicheskikh zatrat gosudarstva na sakharnyy diabet i ikh prognozirovanie
by: Yury Ivanovich Suntsov, et al.
Published: (2005-06-01)

Current approaches to therapy for complications of bone metastases from breast cancer
by: L. G. Zhukova
Published: (2014-07-01)

Pharmacoeconomic analysis of trastuzumab emtanzine comparing to lapatinib + capecitabine in pa-tients with HER2+ breast cancer and central nervous system metastases
by: A. S. Kolbin, et al.
Published: (2018-05-01)

Analysis of effectiveness criteria in pharmacoeconomic studies of hypoglycemic drugs proposed for inclusion into the essential drug list in 2014-2016 in Russia
by: A. A. Mosikyan, et al.
Published: (2018-05-01)